Role of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus
- PMID: 12639401
- DOI: 10.1089/10966200152744463
Role of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus
Abstract
Spirulina, with its high concentration of functional nutrients, is emerging as an important therapeutic food. This study aimed to evaluate the hypoglycemic and hypolipidemic role of Spirulina. Twenty-five subjects with type 2 diabetes mellitus were randomly assigned to receive Spirulina (study group) or to form the control group. At baseline, the control and study groups were matched for various variables. The efficacy of Spirulina supplementation (2 g/day for 2 months) was determined using the preintervention and postintervention blood glucose levels, glycosylated hemoglobin (HbA(1c)) levels, and lipid profiles of the diabetic subjects. Two-month supplementation with Spirulina resulted in an appreciable lowering of fasting blood glucose and postprandial blood glucose levels. A significant reduction in the HbA(1c) level was also observed, indicating improved long-term glucose regulation. With regard to lipids, triglyceride levels were significantly lowered. Total cholesterol (TC) and its fraction, low-density lipoprotein cholesterol (LDL-C), exhibited a fall coupled with a marginal increase in the level of high-density lipoprotein cholesterol (HDL-C). As a result, a significant reduction in the atherogenic indices, TC:HDL-C and LDL-C: HDL-C, was observed. The level of apolipoprotein B registered a significant fall together with a significant increment in the level of apolipoprotein A1. Therefore, a significant and favorable increase in the ratio of A1:B was also noted. These findings suggest the beneficial effect of Spirulina supplementation in controlling blood glucose levels and in improving the lipid profile of subjects with type 2 diabetes mellitus.
Similar articles
-
Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.Clin Ther. 2004 Oct;26(10):1599-607. doi: 10.1016/j.clinthera.2004.10.008. Clin Ther. 2004. PMID: 15598476 Clinical Trial.
-
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.Metabolism. 2008 Nov;57(11):1552-7. doi: 10.1016/j.metabol.2008.06.010. Metabolism. 2008. PMID: 18940393 Clinical Trial.
-
Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.Saudi Med J. 2006 Feb;27(2):174-80. Saudi Med J. 2006. PMID: 16501671
-
Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.Am J Cardiovasc Drugs. 2011;11(2):93-107. doi: 10.2165/11591190-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 21446776 Review.
-
Pitavastatin: novel effects on lipid parameters.Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Atheroscler Suppl. 2011. PMID: 22152282 Review.
Cited by
-
The effect of spirulina sauce on glycemic index, lipid profile, and oxidative stress in type 2 diabetic patients: A randomized double-blind clinical trial.Food Sci Nutr. 2023 Jul 16;11(9):5199-5208. doi: 10.1002/fsn3.3479. eCollection 2023 Sep. Food Sci Nutr. 2023. PMID: 37701187 Free PMC article.
-
Are There Any Beneficial Effects of Spirulina Supplementation for Metabolic Syndrome Components in Postmenopausal Women?Mar Drugs. 2020 Dec 17;18(12):651. doi: 10.3390/md18120651. Mar Drugs. 2020. PMID: 33348926 Free PMC article. Review.
-
Network analysis retrieving bioactive compounds from Spirulina (Arthrospira platensis) and their targets related to systemic lupus erythematosus.PLoS One. 2024 Aug 29;19(8):e0309303. doi: 10.1371/journal.pone.0309303. eCollection 2024. PLoS One. 2024. PMID: 39208266 Free PMC article.
-
Exploring the NRF2/HO-1 and NF-κB Pathways: Spirulina Nanoparticles as a Novel Approach to Combat Diabetic Nephropathy.ACS Omega. 2024 May 21;9(22):23949-23962. doi: 10.1021/acsomega.4c02285. eCollection 2024 Jun 4. ACS Omega. 2024. PMID: 38854532 Free PMC article.
-
Chromatographic Analyses of Spirulina (Arthrospira platensis) and Mechanism of Its Protective Effects against Experimental Obesity and Hepatic Steatosis in Rats.Medicina (Kaunas). 2023 Oct 13;59(10):1823. doi: 10.3390/medicina59101823. Medicina (Kaunas). 2023. PMID: 37893541 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous